Group sequential designs for clinical trials when the maximum sample size is uncertain.
Journal article
Yarahmadi A. et al, (2024), Stat Med
An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus an aminoglycoside + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial-an update to the published protocol.
Journal article
Randremanana RV. et al, (2024), Trials, 25
Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms
Journal article
Citarella BW. et al, (2024), Heliyon, 10, e29591 - e29591
Interpretations of Studies on SARS-CoV-2 Vaccination and Post-acute COVID-19 Sequelae.
Journal article
Gonçalves BP. et al, (2024), Epidemiology (Cambridge, Mass.), 35, 368 - 371
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial - Authors' reply.
Journal article
Peto L. et al, (2024), Lancet (London, England), 403, 1339 - 1340
Expanded Access Programme for the use of tecovirimat for the treatment of monkeypox infection: A study protocol for an Expanded Access Programme.
Journal article
Bourner J. et al, (2024), PloS one, 19
Evaluation of pragmatic oxygenation measurement as a proxy for Covid-19 severity
Journal article
Swets MC. et al, (2023), Nature Communications, 14
A multi-country analysis of COVID-19 hospitalizations by vaccination status.
Journal article
Gonçalves BP. et al, (2023), Med (New York, N.Y.), 4, 797 - 812.e2
The burden and dynamics of hospital-acquired SARS-CoV-2 in England.
Journal article
Cooper BS. et al, (2023), Nature
Author Correction: GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19
Journal article
Pairo-Castineira E. et al, (2023), Nature, 619, E61 - E61
GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19.
Journal article
Pairo-Castineira E. et al, (2023), Nature, 617, 764 - 768
Seroepidemiology of Lassa virus in pregnant women in Southern Nigeria: A prospective hospital-based cohort study.
Journal article
Kayem ND. et al, (2023), PLoS neglected tropical diseases, 17
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19
Journal article
Kartsonaki C. et al, (2023), International Journal of Epidemiology, 52, 355 - 376
Transplacental transfer of Lassa IgG antibodies in pregnant women in Southern Nigeria: A prospective hospital-based cohort study.
Journal article
Kayem ND. et al, (2023), PLoS neglected tropical diseases, 17
Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID-19.
Journal article
Siggins MK. et al, (2023), Immunology, 168, 473 - 492
Facilitating participation in clinical trials during pregnancy.
Journal article
Vousden N. et al, (2023), BMJ, 380
Standard of care for viral haemorrhagic fevers (VHFs): a systematic review of clinical management guidelines for high-priority VHFs
Journal article
Rigby I. et al, (2023), The Lancet Infectious Diseases
Randomised controlled trials for mpox in endemic countries.
Journal article
Rojek A. et al, (2023), Lancet Infect Dis
MOSAIC: A cohort study of human mpox virus disease.
Journal article
Pesonel E. et al, (2023), Wellcome open research, 8
An evaluation of global Chikungunya clinical management guidelines: A systematic review
Journal article
Webb E. et al, (2022), eClinicalMedicine, 54, 101672 - 101672